The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bilenki, L.
Right arrow Articles by Yang, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bilenki, L.
Right arrow Articles by Yang, X.
The Journal of Immunology, 2006, 177: 7067-7075.
Copyright © 2006 by The American Association of Immunologists, Inc.

Adoptive Transfer of CD8{alpha}+ Dendritic Cells (DC) Isolated from Mice Infected with Chlamydia muridarum Are More Potent in Inducing Protective Immunity Than CD8{alpha} DC

Laura Bilenki, Shuhe Wang, Jie Yang, Yijun Fan, Lei Jiao, Antony George Joyee, Xiaobing Han and Xi Yang1

Laboratory for Infection and Immunity, Departments of Immunology and Medical Microbiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada

Chlamydial infections are serious public health concerns worldwide. In this study, we examined the role of dendritic cell (DC) subsets in inducing protective immunity against chlamydial infection using an adoptive transfer approach. We found that CD11c+CD8{alpha}+ (double-positive, DP) DC, compared with CD11c+CD8{alpha} (single-positive, SP) DC isolated from infected mice, are more potent inducers of protective immunity. Specifically, mice pretreated with DPDC from infected mice, upon infection with Chlamydia trachomatis mouse pneumonitis (MoPn), experienced significantly less severe body weight loss and in vivo chlamydial growth. Analysis of MoPn-driven cytokine production by immune cells revealed that mice that were treated with DPDC produced significantly higher levels of Th1 (TNF-{alpha}, IFN-{gamma}, and IL-12) but lower levels of Th2 (IL-4, IL-5, and IL-13)-related cytokines than the recipients of SPDC following infection challenge. Moreover, DPDC-treated mice displayed significantly higher levels of MoPn-specific IgG2a production and delayed-type hypersensitivity responses compared with SPDC-treated mice. Furthermore, DPDC isolated from infected mice produced higher amounts of IL-12 and IL-10 in vitro in comparison with SPDC. These data indicate that CD8{alpha}+ DC have a significantly higher capacity in inducing protective immunity compared with CD8{alpha} DC, demonstrating the crucial role of DC1-like cells in eliciting protection against C. trachomatis infection

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Address correspondence and reprint requests to Dr. Xi Yang, Laboratory for Infection and Immunity, Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Room 523, 730 William Avenue, Winnipeg, Manitoba R3E 0W3, Canada. E-mail address: yangxi{at}cc.umanitoba.ca

2 Abbreviations used in this paper MoPn, Chlamydia trachomatis mouse pneumonitis strain; DC, dendritic cell; DPDC, CD11c+CD8{alpha}+ DC; SPDC, CD11c+CD8{alpha} DC; EB, elementary body; DTH, delayed-type hypersensitivity; iDPDC, infected DPDC; IFU, inclusion-forming unit; iSPDC, infected SPDC; KO, knockout; MOMP, major outer membrane protein; nDPDC, naive DPDC; nSPDC, naive SPDC; SPG, sucrose-phosphate-glutamic acid.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Bai, J. Cheng, X. Gao, A. G. Joyee, Y. Fan, S. Wang, L. Jiao, Z. Yao, and X. Yang
IL-17/Th17 Promotes Type 1 T Cell Immunity against Pulmonary Intracellular Bacterial Infection through Modulating Dendritic Cell Function
J. Immunol., November 1, 2009; 183(9): 5886 - 5895.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
X. Jiang, C. Shen, J. Rey-Ladino, H. Yu, and R. C. Brunham
Characterization of Murine Dendritic Cell Line JAWS II and Primary Bone Marrow-Derived Dendritic Cells in Chlamydia muridarum Antigen Presentation and Induction of Protective Immunity
Infect. Immun., June 1, 2008; 76(6): 2392 - 2401.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Han, Y. Fan, S. Wang, L. Jiao, H. Qiu, and X. Yang
NK Cells Contribute to Intracellular Bacterial Infection-Mediated Inhibition of Allergic Responses
J. Immunol., April 1, 2008; 180(7): 4621 - 4628.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Kim, S. H. Kim, S. Kim, D. Cho, and T. S. Kim
AIMP1/p43 Protein Induces the Maturation of Bone Marrow-Derived Dendritic Cells with T Helper Type 1-Polarizing Ability
J. Immunol., March 1, 2008; 180(5): 2894 - 2902.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. G. Gao, D. F. Wan, and J. R. Gu
Ex vivo Nicotine Stimulation Augments the Efficacy of Therapeutic Bone Marrow-Derived Dendritic Cell Vaccination
Clin. Cancer Res., June 15, 2007; 13(12): 3706 - 3712.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.